[HTML] springer.com

[HTML][HTML] Effects of sacubitril/valsartan on exercise capacity: a prognostic improvement that starts during uptitration

M Mapelli, I Mattavelli, S Paolillo, E Salvioni… - European Journal of …, 2023 - Springer
Purpose Sacubitril/valsartan is a mainstay of the treatment of heart failure with reduced
ejection fraction (HFrEF); however, its effects on exercise performance yielded conflicting …
被引用次数：4 相关文章
[HTML] nih.gov

[HTML][HTML] Effects of sacubitril/valsartan on exercise capacity: a prognostic improvement that starts during uptitration

M Mapelli, I Mattavelli, S Paolillo… - European Journal of …, 2023 - ncbi.nlm.nih.gov
Purpose Sacubitril/valsartan is a mainstay of the treatment of heart failure with reduced
ejection fraction (HFrEF); however, its effects on exercise performance yielded conflicting …

Effects of sacubitril/valsartan on exercise capacity: a prognostic improvement that starts during uptitration

M Mapelli, I Mattavelli, S Paolillo… - … journal of clinical …, 2023 - pubmed.ncbi.nlm.nih.gov
Purpose Sacubitril/valsartan is a mainstay of the treatment of heart failure with reduced
ejection fraction (HFrEF); however, its effects on exercise performance yielded conflicting …

Effects of sacubitril/valsartan on exercise capacity: a prognostic improvement that starts during uptitration

M Mapelli, I Mattavelli, S Paolillo, E Salvioni… - EUROPEAN JOURNAL …, 2023 - air.unimi.it
Purpose: Sacubitril/valsartan is a mainstay of the treatment of heart failure with reduced
ejection fraction (HFrEF); however, its effects on exercise performance yielded conflicting …
[PDF] unimi.it

[PDF][PDF] Effects of sacubitril/valsartan on exercise capacity: a prognostic improvement that starts during uptitration

M Mapelli, I Mattavelli, S Paolillo, E Salvioni, D Magrì… - 2023 - air.unimi.it
Purpose Sacubitril/valsartan is a mainstay of the treatment of heart failure with reduced
ejection fraction (HFrEF); however, its effects on exercise performance yielded conflicting …